Avaleht › Migreen › Pennsylvania
Migreen kliinilised uuringud osariigis Pennsylvania
8 uuringut haiguse Migreen jaoks otsivad osalejaid osariigis Pennsylvania.
Linnad osariigis Pennsylvania
Ametlik uuringutekst (inglise keeles)
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Children's Hospital of Philadelphia, Philadelphia
VärbamineFaas 1
Vanused 6–11 · Kõik sood · Uuendatud 28. sept 2026 · NCT06995729MMA Embolization for Refractory Chronic Migraine
- Thomas Jefferson University Hospital, Philadelphia
Värbamine
Vanused 18–65 · Kõik sood · Uuendatud 25. sept 2026 · NCT06735833Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Clario, Philadelphia
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 24. sept 2026 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- The Children's Hospital of Philadelphia /ID# 270842, Philadelphia
- Frontier Clinical Research - Scottdale /ID# 270854, Scottdale
- Frontier Clinical Research - Smithfield /ID# 270849, Smithfield
VärbamineFaas 3
Vanused 12–17 · Kõik sood · Uuendatud 22. sept 2026 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- Children's Hospital of Philadelphia, Philadelphia
Värbamine
Vanused 10–17 · Kõik sood · Uuendatud 21. sept 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- University of Pennsylvania, Philadelphia
VärbamineFaas 4
Vanused 18–70 · Kõik sood · Uuendatud 16. sept 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Children's Hospital of Philadelphia - Main /ID# 232487, Philadelphia
- Frontier Clinical Research - Scottdale /ID# 231913, Scottdale
- Frontier Clinical Research - Smithfield /ID# 231912, Smithfield
VärbamineFaas 3
Vanused 6–17 · Kõik sood · Uuendatud 14. sept 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Lehigh Center for Clinical Research, Allentown
- Clinical Research Philadelphia, Philadelphia
- Preferred Primary Care Physicians, Inc., Pittsburgh
- ja veel 2
VärbamineFaas 3
Vanused 18–75 · Kõik sood · Uuendatud 20. aug 2026 · NCT07645924Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.